rs1555605093
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_003079.5(SMARCE1):c.1090_1092delCCT(p.Pro364del) variant causes a conservative inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P364P) has been classified as Likely benign.
Frequency
Consequence
NM_003079.5 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- familial meningiomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P, Ambry Genetics
- Coffin-Siris syndrome 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Coffin-Siris syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial multiple meningiomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003079.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMARCE1 | NM_003079.5 | MANE Select | c.1090_1092delCCT | p.Pro364del | conservative_inframe_deletion | Exon 11 of 11 | NP_003070.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMARCE1 | ENST00000348513.12 | TSL:1 MANE Select | c.1090_1092delCCT | p.Pro364del | conservative_inframe_deletion | Exon 11 of 11 | ENSP00000323967.6 | ||
| SMARCE1 | ENST00000578044.6 | TSL:1 | c.880_882delCCT | p.Pro294del | conservative_inframe_deletion | Exon 8 of 8 | ENSP00000464511.1 | ||
| ENSG00000264058 | ENST00000476049.1 | TSL:5 | n.*1438_*1440delCCT | non_coding_transcript_exon | Exon 13 of 13 | ENSP00000463483.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
SMARCE1-related disorder Uncertain:1
The SMARCE1 c.1090_1092delCCT variant is predicted to result in an in-frame deletion (p.Pro364del). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Familial meningioma Uncertain:1
This variant, c.1090_1092delCCT, results in the deletion of 1 amino acid of the SMARCE1 protein (p.Pro364del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SMARCE1-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acid is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1090_1092delCCT variant (also known as p.P364del) is located in coding exon 10 of the SMARCE1 gene. This variant results from an in-frame CCT deletion at nucleotide positions 1090 to 1092. This results in the in-frame deletion of a proline at codon 364. This amino acid position is highly conserved in available vertebrate species. Missense and in-frame variants in SMARCE1 are known to cause neurodevelopmental disorders; however, such associations with increased risk of meningiomas are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Smith JM et al. Nat Genet. 2013 Mar;45(3):295-8). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at